retatrutide efeitos colaterais Retatrutida: nova medicação para obesidade e diabetes tipo 2 com perda de até 24% do peso Retatrutida: desistências por “emagrecer demais”?

Relevant meta-analyses suggest that GLP-1RA treatment exerts more pronounced antitumor effects in prostate cancer, particularly in individuals with coexisting cardiovascular diseases [115]

In the phase 2 dose-escalation study (Jastreboff et al., NEJM, 2023), gastrointestinal adverse events were reported in a substantial proportion of participants, with incidence increasing at higher doses

SIBO can occur for several reasons, impaired gut motility, structural changes in the gut, or other underlying conditions (e.g., diabetes, obesity immune health issues or old age)

A GLP-1 weight loss drug lawsuit gives patients and families a way to hold manufacturers accountable when the risks of these medications outweigh the benefits